Metacrine Posts Data From MET409 Combination Trial In Diabetes, NASH Patients
Inventiva Plans To Start Lanifibranor Combo Study In NASH, Diabetes In 2022
Eli Lilly Shares Positive Tirzepatide Data At EASD Annual Meeting
Bayer's Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes